Acme United (ACU) 15th Annual LD Micro Invitational 2025 summary
Event summary combining transcript, slides, and related documents.
15th Annual LD Micro Invitational 2025 summary
28 Nov, 2025Business overview and strategy
Operates two main product lines: cutting tools and first aid/safety products, with a focus on innovation and timely delivery.
Maintains strong liquidity, aided by divestitures and consistent EBITDA generation; recent sales used to pay down debt.
Holds a leading global position in scissors, with 150 patents and a customer base including major retailers.
Acquisitions have shifted focus from medical instruments to value-added first aid and safety products, with recurring high-margin refill business.
Recent acquisition of Elite First Aid expanded life-saving product offerings, now fully integrated and distributed across all customer segments.
Financial performance and capital allocation
Achieved record EBITDA of $20 million and net income of $10 million last year, with earnings per share at $2.45.
Stock trades at $40, with a $0.60/share dividend that is periodically increased, though recent increases have been paused for market stability.
Growth continued in 2024 despite divestiture of a $12 million business; proceeds used to reduce debt and refocus operations.
Strong cash flow enables inventory purchases, opportunistic acquisitions, and share buybacks.
Innovation and product development
Introduced RFID-enabled first aid kits that automate inventory tracking, refills, and compliance, reducing customer costs by up to 50%.
Patented monitoring system in first aid kits is being rolled out to major US and Canadian corporate clients.
Expanding product lines to include advanced bleed control and ZOLL defibrillators, with integrated training and monitoring.
Plant expansion in Florida for alcohol and lens cleaning wipes, leveraging domestic production to benefit from tariff changes.
Cutting tools segment features advanced materials and coatings, with strong retail and e-commerce presence.
Latest events from Acme United
- Shareholders will vote on director elections, stock option plan expansion, executive pay, and auditor ratification.ACU
Proxy filing27 Mar 2026 - Record 2025 results and Q4 growth, with acquisitions and investments fueling future expansion.ACU
Q4 202527 Feb 2026 - Q2 net income up 29% with margin gains and Elite First Aid acquisition completed.ACU
Q2 20243 Feb 2026 - Q3 net sales fell 4% but net income rose 3% as Europe and product lines outperformed.ACU
Q3 202419 Jan 2026 - Record sales, product innovation, and supply chain shifts drive growth and margin expansion.ACU
17th Annual LD Micro Main Event Conference18 Jan 2026 - Revenue growth, innovation, and acquisitions position the firm for $300M in sales by 2027.ACU
2024 Southwest IDEAS Conference12 Jan 2026 - Record sales and profit growth in 2024, driven by core business and Elite First Aid integration.ACU
Q4 202424 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and say-on-pay frequency.ACU
Proxy Filing1 Dec 2025 - Q1 sales and EPS rose, with first aid and automation offsetting tariff and supply chain risks.ACU
Q1 202528 Nov 2025